This report contains market size and forecasts of Intravitreal Injectable in global, including the following market information:
Global Intravitreal Injectable Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Intravitreal Injectable Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Intravitreal Injectable companies in 2020 (%)
The global Intravitreal Injectable market was valued at 14120 million in 2020 and is projected to reach US$ 18380 million by 2027, at a CAGR of 6.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravitreal Injectable manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravitreal Injectable Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Intravitreal Injectable Market Segment Percentages, By Type, 2020 (%)
Anti-VEGF
Steroids
Others
Global Intravitreal Injectable Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Intravitreal Injectable Market Segment Percentages, By Application, 2020 (%)
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Global Intravitreal Injectable Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Intravitreal Injectable Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravitreal Injectable revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Intravitreal Injectable revenues share in global market, 2020 (%)
Key companies Intravitreal Injectable sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Intravitreal Injectable sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Intravitreal Injectable Market Definition
1.2 Market Segments
1.2.1 Market by Drug
1.2.2 Market by Disease
1.3 Global Intravitreal Injectable Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravitreal Injectable Overall Market Size
2.1 Global Intravitreal Injectable Market Size: 2021 VS 2027
2.2 Global Intravitreal Injectable Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Intravitreal Injectable Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Intravitreal Injectable Players in Global Market
3.2 Top Global Intravitreal Injectable Companies Ranked by Revenue
3.3 Global Intravitreal Injectable Revenue by Companies
3.4 Global Intravitreal Injectable Sales by Companies
3.5 Global Intravitreal Injectable Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Intravitreal Injectable Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Intravitreal Injectable Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intravitreal Injectable Players in Global Market
3.8.1 List of Global Tier 1 Intravitreal Injectable Companies
3.8.2 List of Global Tier 2 and Tier 3 Intravitreal Injectable Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Intravitreal Injectable Market Size Markets, 2021 & 2027
4.1.2 Anti-VEGF
4.1.3 Steroids
4.1.4 Others
4.2 By Type - Global Intravitreal Injectable Revenue & Forecasts
4.2.1 By Type - Global Intravitreal Injectable Revenue, 2016-2021
4.2.2 By Type - Global Intravitreal Injectable Revenue, 2022-2027
4.2.3 By Type - Global Intravitreal Injectable Revenue Market Share, 2016-2027
4.3 By Type - Global Intravitreal Injectable Sales & Forecasts
4.3.1 By Type - Global Intravitreal Injectable Sales, 2016-2021
4.3.2 By Type - Global Intravitreal Injectable Sales, 2022-2027
4.3.3 By Type - Global Intravitreal Injectable Sales Market Share, 2016-2027
4.4 By Type - Global Intravitreal Injectable Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Intravitreal Injectable Market Size, 2021 & 2027
5.1.2 Macular Degeneration
5.1.3 Macular Edema
5.1.4 Uveitis
5.1.5 Retinal Vein Occlusion
5.1.6 Others
5.2 By Application - Global Intravitreal Injectable Revenue & Forecasts
5.2.1 By Application - Global Intravitreal Injectable Revenue, 2016-2021
5.2.2 By Application - Global Intravitreal Injectable Revenue, 2022-2027
5.2.3 By Application - Global Intravitreal Injectable Revenue Market Share, 2016-2027
5.3 By Application - Global Intravitreal Injectable Sales & Forecasts
5.3.1 By Application - Global Intravitreal Injectable Sales, 2016-2021
5.3.2 By Application - Global Intravitreal Injectable Sales, 2022-2027
5.3.3 By Application - Global Intravitreal Injectable Sales Market Share, 2016-2027
5.4 By Application - Global Intravitreal Injectable Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Intravitreal Injectable Market Size, 2021 & 2027
6.2 By Region - Global Intravitreal Injectable Revenue & Forecasts
6.2.1 By Region - Global Intravitreal Injectable Revenue, 2016-2021
6.2.2 By Region - Global Intravitreal Injectable Revenue, 2022-2027
6.2.3 By Region - Global Intravitreal Injectable Revenue Market Share, 2016-2027
6.3 By Region - Global Intravitreal Injectable Sales & Forecasts
6.3.1 By Region - Global Intravitreal Injectable Sales, 2016-2021
6.3.2 By Region - Global Intravitreal Injectable Sales, 2022-2027
6.3.3 By Region - Global Intravitreal Injectable Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Intravitreal Injectable Revenue, 2016-2027
6.4.2 By Country - North America Intravitreal Injectable Sales, 2016-2027
6.4.3 US Intravitreal Injectable Market Size, 2016-2027
6.4.4 Canada Intravitreal Injectable Market Size, 2016-2027
6.4.5 Mexico Intravitreal Injectable Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Intravitreal Injectable Revenue, 2016-2027
6.5.2 By Country - Europe Intravitreal Injectable Sales, 2016-2027
6.5.3 Germany Intravitreal Injectable Market Size, 2016-2027
6.5.4 France Intravitreal Injectable Market Size, 2016-2027
6.5.5 U.K. Intravitreal Injectable Market Size, 2016-2027
6.5.6 Italy Intravitreal Injectable Market Size, 2016-2027
6.5.7 Russia Intravitreal Injectable Market Size, 2016-2027
6.5.8 Nordic Countries Intravitreal Injectable Market Size, 2016-2027
6.5.9 Benelux Intravitreal Injectable Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Intravitreal Injectable Revenue, 2016-2027
6.6.2 By Region - Asia Intravitreal Injectable Sales, 2016-2027
6.6.3 China Intravitreal Injectable Market Size, 2016-2027
6.6.4 Japan Intravitreal Injectable Market Size, 2016-2027
6.6.5 South Korea Intravitreal Injectable Market Size, 2016-2027
6.6.6 Southeast Asia Intravitreal Injectable Market Size, 2016-2027
6.6.7 India Intravitreal Injectable Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Intravitreal Injectable Revenue, 2016-2027
6.7.2 By Country - South America Intravitreal Injectable Sales, 2016-2027
6.7.3 Brazil Intravitreal Injectable Market Size, 2016-2027
6.7.4 Argentina Intravitreal Injectable Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Intravitreal Injectable Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Intravitreal Injectable Sales, 2016-2027
6.8.3 Turkey Intravitreal Injectable Market Size, 2016-2027
6.8.4 Israel Intravitreal Injectable Market Size, 2016-2027
6.8.5 Saudi Arabia Intravitreal Injectable Market Size, 2016-2027
6.8.6 UAE Intravitreal Injectable Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Corporate Summary
7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Major Product Offerings
7.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales and Revenue in Global (2016-2021)
7.1.5 Regeneron Pharmaceuticals (Eylea) Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Intravitreal Injectable Major Product Offerings
7.2.4 Allergan Intravitreal Injectable Sales and Revenue in Global (2016-2021)
7.2.5 Allergan Key News
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Corporate Summary
7.3.2 EyePoint Pharmaceuticals Business Overview
7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Major Product Offerings
7.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Sales and Revenue in Global (2016-2021)
7.3.5 EyePoint Pharmaceuticals Key News
7.4 Genentech
7.4.1 Genentech Corporate Summary
7.4.2 Genentech Business Overview
7.4.3 Genentech Intravitreal Injectable Major Product Offerings
7.4.4 Genentech Intravitreal Injectable Sales and Revenue in Global (2016-2021)
7.4.5 Genentech Key News
7.5 Kanghong Pharmaceutical
7.5.1 Kanghong Pharmaceutical Corporate Summary
7.5.2 Kanghong Pharmaceutical Business Overview
7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Major Product Offerings
7.5.4 Kanghong Pharmaceutical Intravitreal Injectable Sales and Revenue in Global (2016-2021)
7.5.5 Kanghong Pharmaceutical Key News
8 Global Intravitreal Injectable Production Capacity, Analysis
8.1 Global Intravitreal Injectable Production Capacity, 2016-2027
8.2 Intravitreal Injectable Production Capacity of Key Manufacturers in Global Market
8.3 Global Intravitreal Injectable Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intravitreal Injectable Supply Chain Analysis
10.1 Intravitreal Injectable Industry Value Chain
10.2 Intravitreal Injectable Upstream Market
10.3 Intravitreal Injectable Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intravitreal Injectable Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Intravitreal Injectable in Global Market
Table 2. Top Intravitreal Injectable Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Intravitreal Injectable Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Intravitreal Injectable Revenue Share by Companies, 2016-2021
Table 5. Global Intravitreal Injectable Sales by Companies, (K Units), 2016-2021
Table 6. Global Intravitreal Injectable Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Intravitreal Injectable Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Intravitreal Injectable Product Type
Table 9. List of Global Tier 1 Intravitreal Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravitreal Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical